“Safety Profile of Lebrikizumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: Integrated Data Used in the US Prescribing Information”. SKIN The Journal of Cutaneous Medicine 9, no. 2 (April 13, 2025): s572. Accessed June 8, 2025. https://skin.dermsquared.com/skin/article/view/3385.